Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-24-020698
Filing Date
2024-12-16
Accepted
2024-12-16 19:44:24
Documents
2
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1474
2 POA exhibit24.htm EX-24 502118
  Complete submission text file 0001062993-24-020698.txt   505395
Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PALVELLA THERAPEUTICS, INC. 125 STRAFFORD DRIVE WAYNE PA 19087
Business Address
Wessel Tadd S. (Reporting) CIK: 0002048706 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37471 | Film No.: 241553292